Publication dates

All regions

Prostate Cancer Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, more »


 
1-20 of about 5 900 reports for Prostate Cancer

Prostate Cancer Drug Pipeline Update 2014

Prostate Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To alternatives. Establishing the optimal timing of antihormonal therapy will provide the key to market growth.There are today 350 companies plus partners developing 415 drugs targeting prostate cancer ...

Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any prostate cancer drug ...

 Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Status and exclusivity details of metastatic hormone refractory (castration resistant, androgen-independent) prostate cancer key products to exploit opportunities for generic drug development ...

Drug and Medication Industry: Prostate Cancer – Pipeline Review, H1 2012

Drug and Medication Industry: Prostate Cancer – Pipeline Review, H1 2012

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of prostate cancer- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

MetaStat, Inc. (MTST) - Product Pipeline Analysis, 2014 Update

MetaStat, Inc. (MTST) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... In adenocarcinoma of the lung. Metastat also offers menacalc prostate, a diagnostic for prostate cancer; and menabloc, a platform technology that develops therapies that can preemptively reduce or eliminate ...

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Changes. The company offers technology for cancer detection, diagnosis, progression, and prognosis. It conducts clinical studies in ovarian and prostate cancers with the us. The company operates ...

BioTime, Inc. (BTX) - Product Pipeline Analysis, 2014 Update

BioTime, Inc. (BTX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Panc-dx - lung cancer - product description 21panc-dx - prostate cancer - product status 22panc-dx - prostate cancer - product description 22premvia - product status 23 ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

InterGenetics Incorporated - Strategic SWOT Analysis Review

InterGenetics Incorporated - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Risk. The comapny also has a range of research pipeline of predictive tests for other cancers such as ovarian, colon, and prostate cancer. Intergenetics is headquartered in oklahoma, the us ...

EDAP TMS S.A. (Symbol:EDAP) SWOT Analysis, Strategy, Revenues and Profits

EDAP TMS S.A. (Symbol:EDAP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... Hifu) and urology devices and services (uds). The principal product of the company is ablatherm used as the hifu treatment for localized prostate cancer. Its services include mobile services for hifu ...

About 2 400 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • Prostate Cancer
  • December 2012
    20 pages
  • Prostate Cancer  

    Cancer  

  • Canada  

View report >

3 Companies for Prostate Cancer

Read our Company Profiles

Management Strategies

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.